Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 18, 2020

Natur International Corp.

(Exact name of registrant as specified in its charter)

Wyoming

000-54917

45-5547692

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

Parnassus Tower

Locatellikade 1

1076 AZ Amsterdam

The Netherlands

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +31 20 578 7700

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name on exchange on which registered
None		-		-

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, Compensation Arrangements of Certain Officers

Resignation of Mrs. Storms and Mr. Bay from the Board and the appointment of Karen Brink in the vacant position

On February 21, 2020 Mrs. Nina Storms submitted a resignation letter as Board member for personal reasons which was accepted by the Board on February 29, 2020.

At the same date, the Board accepted the nomination by executive management to appoint Mrs. Karen Brink in the vacant position. Ms. Brink has been an investor during the past five years through NL Life Sciences Holding BV, one of our principal investors. Ms. Brink has been selected as a director because of her investment and financial experience and her familiarity with the Company. Mrs. Brink is currently managing a number of companies of the Family Foundation and is involved in and donor to a number of international charities.

On March 18, 2020 Mr. Anthony Bay rendered his resignation as member of the Board; Mr. Bay has helped the company through difficult times but the company has now strong leadership in place and a strong, large Board. Mr. Bay is involved in a number of other projects that needs his time and attention in these challenging times.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.